ACKERMANN, JEAN,BRUGGER, STEPHAN,CONTE, AURELIA,HUNZIKER, DANIEL,NEIDHART, WERNER,NETTEKOVEN, MATTHIAS,SCHULZ-GASCH, TANJA,WERTHEIMER, STANLEY
申请号：
SG2012025334
公开号：
SG179882A1
申请日:
2010.10.12
申请国别(地区):
SG
年份:
2012
代理人:
摘要：
Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions as HSL inhibitors for the treatment of diabetes, wherein R1,R2, R3, Ca and Cb have the significance given in claim 1.
